Arens Timothy J.'s most recent trade in Surmodics, Inc. was a trade of 67,299 Common Stock done . Disclosure was reported to the exchange on Nov. 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 67,299 | 0 (0%) | 0% | - | Common Stock | |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 26,548 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 25,016 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 18,337 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 17,883 | 0 | - | - | Employee Stock Options (right to buy) | |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 15,668 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 10,653 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2025 | 2,615 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Arens Timothy J. | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.91 per share. | 04 Dec 2024 | 1,265 | 67,299 (0%) | 0% | 39.9 | 50,486 | Common Stock |
| Surmodics Inc | J. Arens Timothy | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.45 per share. | 30 Nov 2024 | 1,786 | 68,564 (0%) | 0% | 39.5 | 70,458 | Common Stock |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 39.44 per share. | 26 Nov 2024 | 7,009 | 70,350 (0%) | 0% | 39.4 | 276,453 | Common Stock |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.20 per share. | 16 Aug 2024 | 18,447 | 94,088 (0%) | 0% | 33.2 | 612,440 | Common Stock |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2024 | 18,447 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.06 per share. | 16 Aug 2024 | 16,729 | 77,359 (0%) | 0% | 40.1 | 670,164 | Common Stock |
| Surmodics Inc | Arens Timothy J. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 26,548 | 26,548 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | J. Arens Timothy | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 8,323 | 75,641 (0%) | 0% | 0 | Common Stock | |
| Surmodics Inc | Timothy Arens J. | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 1,094 | 67,318 (0%) | 0% | 32.8 | 35,905 | Common Stock |
| Surmodics Inc | Timothy Arens J. | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 693 | 68,412 (0%) | 0% | 32.8 | 22,744 | Common Stock |
| Surmodics Inc | J. Arens Timothy | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 650 | 69,105 (0%) | 0% | 32.8 | 21,333 | Common Stock |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 25,016 | 25,016 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 7,196 | 69,755 (0%) | 0% | 0 | Common Stock | |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. | 30 Nov 2022 | 692 | 62,559 (0%) | 0% | 36.1 | 25,002 | Common Stock |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. | 30 Nov 2022 | 650 | 63,251 (0%) | 0% | 36.1 | 23,485 | Common Stock |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.02 per share. | 25 Nov 2022 | 543 | 63,901 (0%) | 0% | 36.0 | 19,559 | Common Stock |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.91 per share. | 13 May 2022 | 151 | 64,444 (0%) | 0% | 35.9 | 5,422 | Common Stock |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 18,337 | 18,337 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 4,552 | 64,595 (0%) | 0% | 0 | Common Stock | |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.93 per share. | 30 Nov 2021 | 650 | 60,043 (0%) | 0% | 43.9 | 28,555 | Common Stock |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.85 per share. | 25 Nov 2021 | 544 | 61,042 (0%) | 0% | 47.8 | 26,030 | Common Stock |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.77 per share. | 25 Nov 2021 | 349 | 60,693 (0%) | 0% | 45.8 | 15,974 | Common Stock |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2021 | 12,498 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.95 per share. | 31 Aug 2021 | 12,498 | 69,996 (0%) | 0% | 23.9 | 299,327 | Common Stock |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.07 per share. | 31 Aug 2021 | 8,410 | 61,586 (0%) | 0% | 60.1 | 505,189 | Common Stock |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.24 per share. | 13 May 2021 | 134 | 57,498 (0%) | 0% | 53.2 | 7,134 | Common Stock |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2021 | 8,359 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.25 per share. | 24 Feb 2021 | 8,359 | 65,076 (0%) | 0% | 20.3 | 169,270 | Common Stock |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.70 per share. | 24 Feb 2021 | 7,444 | 57,632 (0%) | 0% | 51.7 | 384,855 | Common Stock |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2021 | 2,614 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics Inc | Timothy J. Arens | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.03 per share. | 24 Feb 2021 | 2,614 | 56,717 (0%) | 0% | 21.0 | 54,972 | Common Stock |